First Trust Advisors LP Reduces Stock Holdings in The Chemours Company

First Trust Advisors LP reduced its Chemours stake by 45.7% after the company missed Q2 earnings, causing an 18.3% stock drop. Analysts retain a Moderate Buy rating despite litigation costs.